Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
17 hedge funds and large institutions have $1.7M invested in Genetic Technologies Ltd. in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
91% more capital invested
Capital invested by funds: $895K → $1.7M (+$810K)
21% more funds holding
Funds holding: 14 → 17 (+3)
67% less call options, than puts
Call options by funds: $210K | Put options by funds: $629K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$370K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$134K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$108K |
| 4 |
Goldman Sachs
New York
|
+$98.8K |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$46.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$75K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.4K |
GENE Hedge Fund Activity: Q1 2021 in Review
17 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2021, worth a combined $1.7M — up 91% from $895K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GENE positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $370K. The largest seller was Credit Suisse, exiting entirely with an estimated $75K sold.
- 17 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2021, up from 14 in Q4 2020.
- Funds reported $1.7M of Genetic Technologies Ltd. stock for Q1 2021, up 91% quarter-over-quarter.
- 5 funds opened new Genetic Technologies Ltd. positions in Q1 2021 and 2 closed out, a net change of +3 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2021 was Citadel Advisors, an estimated $370K added.
- The largest Genetic Technologies Ltd. seller in Q1 2021 was Credit Suisse, an estimated $75K sold.
Based on aggregated 13F filings for Q1 2021.